Post-earnings recap
Reported
Wed, Jul 31, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Teladoc Health reported a loss that was slightly worse than expected, leading to a 2.71% decline in its stock price. The lack of revenue data and management commentary leaves investors with limited insight into the company's current performance and future outlook. The market reaction suggests some disappointment among investors regarding the earnings report.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.41 | N/A | -6.96% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.